NewLimit | Extending human healthspan (original) (raw)

Epigenetically reprogramming cells to younger states

NewLimit is inventing medicines to restore youthful function in old cells by reprogramming the epigenome. We leverage enabling technologies spanning single cell genomics, machine learning, and high-throughput functional assays to reveal epigenetic features of aging and discover rejuvenating interventions.